Clinical trialNCT03715933RecruitingPhase 1Interventional

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

SponsorInhibrx Biosciences, IncEnrollment411Colorectal AdenocarcinomaEwing Sarcoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Clinical Lead
Inhibrx Biosciences, Inc
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France

Centre Leon Berard
Lyon, France
Mehdi Brahmi, MD
Recruiting
Gustave Roussy
Villejuif, France
Pablo Berlanga, MD
Recruiting

Italy

la Fondazione E L'Istituto Di Candiolo
Candiolo, Italy
Sandra Aliberti, MD
Recruiting
Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, Italy
Roberto Luksch, MDSalvatore Provenzano, MD
Recruiting

Netherlands

University Medical Center Groningen
Groningen, Netherlands
Jacco de Haan, MD
Recruiting
Academisch Ziekenhuis Leiden
Leiden, Netherlands
André (Hans) Gelderblom, MD
Recruiting

Spain

Hospital Universitario Vall D'Hebron
Barcelona, Spain
Elena Elez, MD
Recruiting
Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
Ana Sebio Garcia, MD
Recruiting
Hospital Clinico San Carlos
Madrid, Spain
Antonio Casado Herraez
Recruiting

United Kingdom

Great North Children'S Hospital
London, United Kingdom
Quentin Campbell-Hewson, MD
Recruiting
the Royal Marsden Nhs Foundation Trust
London, United Kingdom
Andrea Napolitano, MD
Recruiting
University College London Hospital
London, United Kingdom
Sandra Strauss, MD
Recruiting
Royal Manchester Children'S Hospital
Manchester, United Kingdom
Bernadette Maria Dymphna Brennan
Recruiting

United States

Honorhealth Research Institute
Scottsdale, Arizona, United States
Completed
Precision Nextgen Oncology and Research
Beverly Hills, California, United States
Kamalesh Sankhala, MD
Recruiting
City of Hope
Duarte, California, United States
Marwan Fakih, MD
Recruiting
Valkyrie Clinical Trials
Los Angeles, California, United States
David Berz, MD
Recruiting
University of California, San Diego (ucsd) - Moores Cancer Center
San Diego, California, United States
Withdrawn
University of California, San Francisco (ucsf)
San Francisco, California, United States
Varun Monga, MD
Recruiting
Sarcoma Oncology Center
Santa Monica, California, United States
Sant P Chawla, MD
Recruiting
University of Colorado Hospital
Aurora, Colorado, United States
Christopher Lieu, MD
Recruiting
Emory University - Winship Cancer Institute
Atlanta, Georgia, United States
Olatunji Alese, MD
Recruiting
the University of Chicago
Chicago, Illinois, United States
Completed
University of Michigan
Ann Arbor, Michigan, United States
Rashmi Chugh, MD
Recruiting
Start Midwest Michigan, Pc
Grand Rapids, Michigan, United States
Nehal Lakhani, MD
Recruiting
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
New York, New York, United States
Emily Slotkin, MD
Recruiting
Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Michael D Deel, MD
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Completed
Oregon Health & Science University
Portland, Oregon, United States
Michael Heinrich, MD
Recruiting
Children'S Hospital of Philadelphia- Center for Childhood Cancer Research
Philadelphia, Pennsylvania, United States
Theodore Laetsch, MD
Recruiting
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, United States
Lee Hartner, MD
Recruiting
Vanderbilt University School of Medicine
Nashville, Tennessee, United States
Elizabeth Davis, MD
Recruiting
Ut Md Anderson Cancer Center
Houston, Texas, United States
David Hong, MD
Recruiting
Next Oncology
San Antonio, Texas, United States
Completed
University of Virginia
Charlottesville, Virginia, United States
Ludimila Cavalcante, MD
Recruiting
Next Oncology - Virginia
Fairfax, Virginia, United States
Alexander Spira, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bevacizumab →Fluorouracil →INBRX-109Irinotecan →Leucovorin →Temozolomide →Tipiracil / trifluridine →Carboplatin →Pemetrexed →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Oct 2018
Primary completion: 31 Dec 2028
Completion: 30 Jun 2029
Last update posted: 22 May 2026
Registered enrollment: 411
Registry id: NCT03715933

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.